UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2022-11-09 | Future report Set alerts | |
| Q3 2022 | 2022-08-04 | 0.43 | 0.43 |
| Q2 2022 | 2022-05-05 | 0.47 | 0.47 |
| Q1 2022 | 2022-02-02 | 0.63 | 0.63 |
| Q4 2021 | 2021-11-11 | 0.63 | 0.63 |
| Q3 2021 | 2021-07-29 | 0.68 | 0.68 |
| Q2 2021 | 2021-05-06 | 0.57 | 0.57 |
| Q1 2021 | 2021-02-04 | 0.50 | 0.50 |
| Q4 2020 | 2020-11-12 | 0.00 | 0.00 |
| Q3 2020 | 2020-07-30 | -0.11 | -0.21 |
| 2016-06-22 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-06-22 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-06-20 | Reiterated Rating | KeyBanc | Buy | |
| 2016-06-20 | Reiterated Rating | KeyCorp | Buy | |
| 2016-06-02 | Upgrade | Wells Fargo | Underperform to Market Perform | $23.00 to $31.00 |
| 2016-06-02 | Upgrade | Wells Fargo & Co. | Underperform to Market Perform | $23.00 to $31.00 |
| 2016-05-19 | Reiterated Rating | Piper Jaffray | Overweight | $31.00 to $30.00 |
| 2016-05-19 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $31.00 to $30.00 |
| 2016-05-14 | Initiated Coverage | Oppenheimer | Buy | |
| 2016-05-13 | Reiterated Rating | Oppenheimer | Top Pick | $36.00 |
| 2016-05-12 | Reiterated Rating | B. Riley | Neutral | $31.00 |
| 2016-05-06 | Reiterated Rating | Robert W. Baird | Buy | $34.00 |
| 2016-05-06 | Reiterated Rating | B. Riley | Neutral | $31.00 |
| 2016-04-20 | Initiated Coverage | BB&T Corp. | Hold | |
| 2016-04-01 | Reiterated Rating | Oppenheimer | Outperform | $30.00 to $36.00 |
| 2016-03-29 | Reiterated Rating | Cowen and Company | Outperform | $34.00 to $36.00 |
| 2016-03-15 | Boost Price Target | Raymond James | $33.00 to $35.00 | |
| 2016-03-15 | Boost Price Target | Raymond James Financial Inc. | $33.00 to $35.00 | |
| 2016-03-14 | Boost Price Target | Morgan Stanley | Equal Weight | $30.00 to $32.00 |
| 2016-03-10 | Downgrade | Piper Jaffray | Overweight to Neutral | $31.00 |
| 2016-02-13 | Reiterated Rating | B. Riley | Neutral | $31.00 |
| 2016-02-08 | Reiterated Rating | B. Riley | Neutral | $29.00 to $31.00 |
| 2016-02-05 | Boost Price Target | Robert W. Baird | Outperform | $32.00 to $34.00 |
| 2016-02-05 | Boost Price Target | Nomura | Neutral | $25.00 to $28.00 |
| 2016-02-05 | Boost Price Target | Barclays | Equal Weight | $28.00 to $30.00 |
| 2016-02-05 | Boost Price Target | Nomura Holdings Inc. | Neutral | $25.00 to $28.00 |
| 2016-02-05 | Boost Price Target | Barclays PLC | Equal Weight | $28.00 to $30.00 |
| 2016-01-27 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-01-26 | Upgrade | Oppenheimer | Market Perform to Outperform | $25.00 to $30.00 |
| 2016-01-21 | Lower Price Target | Goldman Sachs | $36.00 to $35.00 | |
| 2016-01-21 | Lower Price Target | Goldman Sachs Group Inc. | $36.00 to $35.00 | |
| 2016-01-19 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $34.00 to $30.00 |
| 2015-12-28 | Reiterated Rating | B. Riley | Neutral | $29.00 |
| 2015-12-23 | Reiterated Rating | B. Riley | Neutral | $29.00 |
| 2015-12-15 | Upgrade | Wells Fargo | Sector Weight to Overweight | |
| 2015-12-15 | Upgrade | KeyBanc | Sector Weight to Overweight | $33.00 |
| 2015-11-18 | Reiterated Rating | B. Riley | Neutral | $29.00 |
| 2015-11-17 | Upgrade | Goldman Sachs | Neutral to Buy | $35.00 |
| 2015-11-14 | Reiterated Rating | Piper Jaffray | Buy | $34.00 to $31.00 |
| 2015-11-13 | Lower Price Target | Nomura | Neutral | $26.00 to $25.00 |
| 2015-11-13 | Reiterated Rating | B. Riley | Neutral | $29.00 |
| 2015-11-10 | Lower Price Target | Oppenheimer | Market Perform | $30.00 to $25.00 |
| 2015-10-28 | Reiterated Rating | Cowen and Company | Buy | $32.00 |
| 2015-10-21 | Downgrade | Wells Fargo | Outperform to Underperform | |
| 2015-09-23 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-08-17 | Reiterated Rating | Nomura | Neutral | $32.00 to $26.00 |
| 2015-08-12 | Boost Price Target | Cowen and Company | Outperform | $30.00 to $32.00 |
| 2015-08-12 | Downgrade | B. Riley | Neutral | $30.00 |
| 2015-08-10 | Lower Price Target | Barclays | Equal Weight | $33.00 to $28.00 |
| 2015-08-10 | Upgrade | Johnson Rice | Hold to Accumulate | |
| 2015-08-07 | Lower Price Target | Robert W. Baird | Outperform | $40.00 to $33.00 |
| 2015-08-07 | Downgrade | B. Riley | Buy to Neutral | $37.00 to $30.00 |
| 2015-08-04 | Lower Price Target | Buckingham Research | Neutral | $33.00 to $31.00 |
| 2015-07-28 | Reiterated Rating | Piper Jaffray | Overweight | $37.00 to $36.00 |
| 2015-06-24 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-06-02 | Set Price Target | Piper Jaffray | Buy | $37.00 |
| 2015-05-11 | Upgrade | Raymond James | Market Perform to Outperform | $35.00 |
| 2015-05-11 | Reiterated Rating | B. Riley | Buy | $37.00 |
| 2015-05-10 | Reiterated Rating | Nomura | Neutral | $33.00 |
| 2015-04-01 | Reiterated Rating | Oppenheimer | Market Perform | $36.00 |
| 2015-03-25 | Boost Price Target | Robert W. Baird | Outperform | $36.00 to $40.00 |
| 2015-02-16 | Reiterated Rating | B. Riley | Buy | $37.00 |
| 2015-02-08 | Reiterated Rating | B. Riley | Buy | $35.00 to $37.00 |
| 2015-02-06 | Boost Price Target | Barclays | Equal Weight | $29.00 to $33.00 |
| 2015-01-09 | Initiated Coverage | Nomura | Neutral | $30.00 |
| 2014-12-17 | Initiated Coverage | Piper Jaffray | Overweight | $37.00 |
| 2014-12-16 | Initiated Coverage | Cowen and Company | Outperform | |
| 2014-12-12 | Reiterated Rating | Bank of America | Buy | $33.00 to $34.00 |
| 2014-12-12 | Reiterated Rating | Bank of America Corp. | Buy | $33.00 to $34.00 |
| 2014-12-11 | Initiated Coverage | Raymond James | Market Perform | |
| 2014-11-14 | Reiterated | B. Riley & Co. | Buy | $32 to $35 |
| 2014-11-14 | Boost Price Target | Robert W. Baird | Outperform | $32.00 to $35.00 |
| 2014-11-14 | Boost Price Target | B. Riley | Buy | $32.00 to $35.00 |
| 2014-10-10 | Reiterated Rating | Bank of America | Buy | $29.00 to $31.00 |
| 2014-09-02 | Reiterated Rating | Morgan Stanley | Overweight | $30.00 |
| 2014-07-29 | Upgrade | Citigroup Inc. | Neutral to Buy | |
| 2014-06-24 | Initiated Coverage | Morgan Stanley | Buy to Overweight | $30.00 |
| 2014-05-20 | Reiterated Rating | Wells Fargo & Co. | Outperform | |
| 2014-05-20 | Reiterated Rating | Wells Fargo | Outperform | |
| 2014-05-06 | Reiterated | B. Riley & Co. | Buy | $34 to $32 |
| 2014-05-06 | Lower Price Target | Sterne Agee CRT | Buy | $32.00 to $30.00 |
| 2014-05-06 | Lower Price Target | B. Riley | Buy | $34.00 to $32.00 |
| 2014-05-02 | Reiterated Rating | Citigroup Inc. | Hold | $29.00 |
| 2014-04-02 | Lower Price Target | Sterne Agee CRT | Buy | $33.00 to $32.00 |
| 2014-01-29 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | |
| 2014-01-29 | Upgrade | Wells Fargo | Market Perform to Outperform | |
| 2014-01-28 | Reiterated Rating | Credit Suisse | Neutral to Buy | $27.65 to $33.00 |
| 2014-01-28 | Upgrade | Sterne Agee CRT | Neutral to Buy | $33.00 |
| 2014-01-02 | Boost Price Target | Sterne Agee CRT | $28.00 to $33.00 | |
| 2013-12-16 | Initiated Coverage | KeyBanc | Hold | |
| 2013-10-07 | Initiated Coverage | Wells Fargo & Co. | Market Perform | |
| 2013-10-07 | Initiated Coverage | Wells Fargo | Market Perform | |
| 2013-08-02 | Reiterated | B. Riley & Co. | Buy | $34 to $33 |
| 2012-08-28 | Reiterated | Caris & Company | Buy | $31 to $32 |
| 2012-07-19 | Upgrade | Caris & Company | Above Average to Buy | $31 to $31 |
| 2012-02-03 | Downgrade | Caris & Company | Buy to Above Average | $26 to $26 |
| 2011-11-17 | Reiterated | RBC Capital Mkts | Sector Perform | $19 to $22 |
| 2011-11-17 | Downgrade | Barclays Capital | Overweight to Equal Weight | $18 to $21 |
| 2011-08-05 | Upgrade | Caris & Company | Above Average to Buy | $21 |
| 2011-06-17 | Reiterated | Caris & Company | Above Average | $18 to $20 |
| 2011-04-20 | Initiated | Barclays Capital | Overweight | $18 |
| 2011-02-04 | Reiterated | Caris & Company | Above Average | $14.50 to $17.50 |
| 2010-05-03 | Reiterated | Caris & Company | Above Average | $9.50 to $11 |
| 2016-06-22 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-06-22 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-06-20 | Reiterated Rating | KeyBanc | Buy | |
| 2016-06-20 | Reiterated Rating | KeyCorp | Buy | |
| 2016-06-02 | Upgrade | Wells Fargo | Underperform to Market Perform | $23.00 to $31.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SBH 162 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 16.43M |
| FMR LLC | 16.05M |
| Vanguard Group, Inc | 11.81M |
| Arrowpoint Asset Management, LLC | 11.00M |
| ALLIANCEBERNSTEIN L.P. | 8.01M |
| JANUS CAPITAL MANAGEMENT LLC | 6.97M |
| BlackRock Fund Advisors | 5.60M |
| Perkins Investment Management, LLC | 4.77M |
| BlackRock Institutional Trust Company, N.A. | 4.44M |
| LSV ASSET MANAGEMENT | 4.23M |
| Champlain Investment Partners, LLC | 4.11M |
| STATE STREET CORP | 3.97M |
| Fisher Asset Management, LLC | 3.55M |
| Polaris Capital Management, LLC | 2.59M |
| DIMENSIONAL FUND ADVISORS LP | 2.46M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Brickman Christian A. | 0.16% (247705) | KMB / SBH / |
| WINTERHALTER GARY Chairman, President & CEO | 0.09% (140404) | SBH / |
| RABIN EDWARD W | 0.05% (70000) | PVTB / SBH / WMS / |
| EISENBERG MARSHALL E | 0.04% (64896) | SBH / |
| MILLER JOHN A | 0.03% (44698) | SBH / |
| MCMASTER ROBERT R | 0.03% (40630) | CRS / SBH / |
| SPINOZZI MICHAEL G President-Sally Beauty Supply | 0.02% (38553) | SBH / |
| Golliher John R President-Beauty Systems Group | 0.02% (33080) | SBH / |
| Grimes Donald T SVP, CFO & COO | 0.02% (26150) | SBH / WWW / |
| FLAHERTY MARK J SVP and CFO | 0.02% (25290) | SBH / |
| Haltom Matthew Olen Senior Vice President, General | 0.01% (19578) | SBH / |
| Spinks Mark Gregory President-Beauty Systems Group | 0.01% (17820) | SBH / |
| Minton Janna VP, CAO & Controller | 0.01% (15389) | SBH / |
| McDermott Carrie S. President-Sally Beauty Supply | 0.01% (15154) | DSW / SBH / |
| Roos Raal H SVP, Gen. Counsel & Secretary | 0.01% (11685) | SBH / |
| Leite Sharon M President-Sally Beauty Supply | 0.01% (10235) | PIR / SBH / |
| Sherman Scott C SVP & CHRO | 0.01% (8203) | SBH / |
UM